- Donna Marie Curran of MSKCC was quoted in an article published by Nurse.com about the impact that oncology nurses have on guiding head and neck cancer patients through survivorship struggles.
- MSKCC was featured in a PRWeb announcement for saving $1 million per year in energy costs.
- A recent MSKCC study found men and women who had ever used 100 cigarettes in their lifetime were 1.45 times as likely as non tobacco users to die from gastric cancer after curative surgical resection.
Author Archives: Mark
MSKCC in the News: June 28 – July 27
- Computerworld reports that Stephen Chou, a Princeton engineering professor, is working with researchers at MSKCC to use nanotechnology to develop tests to detect diseases, like cancer and Alzheimer’s disease.
- A study authored by MSKCC doctors published in the Journal of the American College of Surgeons confirmed that their early analysis of the NanoKnife® System demonstrated safety for treating liver malignancies adjacent to blood vessels, potentially expanding therapeutic options for physicians in previously challenging areas.
MSKCC in the News: June 14 – June 27
- In a New York Magazine article, MSKCC’s Dr. Robert C. Kurtz explores the topic of whether or not soy milk is healthier than skim milk.
- A press release posted on MarketWatch announced that the Center for Medical Technology Policy (CMTP) published its official Effectiveness Guidance Document for how to better incorporate patient-reported outcomes into studies that enroll adult cancer patients. This guidance was developed in collaboration with Dr. Ethan Basch, of MSKCC, Dr. Amy Abernethy, MD, of Duke Cancer institute, and an expert working group of patient advocates, oncologists, researchers and life sciences and other experts.
- Dr. Clifford A. Hudis of MSKCC is quoted in a New York Times article about a drug, known as T-DM1, which delivers a powerful poison to tumors without some of the side effects of traditional treatments and also appears to substantially prolong lives.